{"id":2657,"date":"2017-09-25T05:13:13","date_gmt":"2017-09-25T05:13:13","guid":{"rendered":"http:\/\/europeanvenousforum.org\/?page_id=2657"},"modified":"2017-09-25T05:13:54","modified_gmt":"2017-09-25T05:13:54","slug":"18th-evf-porto-industry-symposia","status":"publish","type":"page","link":"https:\/\/europeanvenousforum.org\/index.php\/18th-evf-porto-industry-symposia\/","title":{"rendered":"18th EVF Porto Industry Symposia"},"content":{"rendered":"

Industry Sponsored Symposia<\/strong><\/span><\/h2>\n

Click here<\/a><\/strong><\/em> to download the Programme<\/a><\/p>\n

<\/a><\/p>\n

<\/h3>\n


\nThursday, June 29, 2017<\/span><\/strong><\/h3>\n\n<\/thead>\n\n\n\n\n\n\n\n\n\n\n\n
12:00 \u2013 13:00\u00a0<\/strong><\/td>\nIndustry Session: Progression of Chronic Venous Disease: Where are we today?<\/strong>(Supported by an educational grant from Servier)<\/em><\/p>\n

Chairperson(s): Armando Mansilha, Andre Van Rij<\/td>\n

Archive Room<\/strong><\/td>\n<\/tr>\n
12:00<\/td>\nEvolution of chronic venous disease. Update of epidemiological data. <\/strong>Armando Mansilha<\/em>
\n<\/strong><\/td>\n		<\/td>\n<\/tr>\n
12:15<\/td>\nPathophysiology of progression of chronic venous disease. <\/strong>Andre Van Rij<\/em><\/td>\n<\/td>\n<\/tr>\n
12:30<\/td>\nTherapeutic options to delay the progression. <\/strong>Marc Vuylsteke<\/em><\/td>\n<\/td>\n<\/tr>\n
12:45<\/td>\nPanel Discussion<\/strong><\/td>\n<\/td>\n<\/tr>\n
13:00 \u2013 14:00\u00a0<\/strong><\/td>\nLunch and Visit to Exhibition<\/strong><\/td>\nExhibition Hall<\/strong><\/td>\n<\/tr>\n
14:00 \u2013 15:00\u00a0<\/strong><\/td>\nIndustry Session: The value of Glycosaminoglycan in Venous Disease<\/strong>(Supported by an educational grant from Alfa Wassermann)<\/em><\/p>\n

Chairperson(s): Jaweed Fareed, Frederico Bastos Goncalves<\/td>\n

Archive Room<\/strong><\/td>\n<\/tr>\n
14:00<\/td>\nPleiotropic activities that affect multiple sites of venous disease. <\/strong>Ferdinando Mannello<\/em>
\n<\/strong><\/td>\n		<\/td>\n<\/tr>\n
14:20<\/td>\nReview of clinical trials on the reduction of symptoms and ulcer healing. <\/strong>Tomasz Urbanek<\/em>
\n<\/strong><\/td>\n		<\/td>\n<\/tr>\n
14:40<\/td>\nPrevention of recurrent deep venous thrombosis as the key to preventing post-thrombotic syndrome. <\/strong>Andrew Nicolaides<\/em><\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

<\/a><\/p>\n

\u00a0Friday, June 30, 2017<\/strong><\/span><\/h3>\n\n\n\n\n\n\n\n
11:00 \u2013 12:00\u00a0<\/strong><\/td>\nIndustry Session: New Data on Chronic Venous Disease, New Place for Cyclo 3<\/strong>(Supported by an educational grant from Pierre Fabre)<\/em><\/p>\n

Chairperson(s): Arkadiusz Jawien, Armando Mansilha<\/td>\n

Archive Room<\/strong><\/td>\n<\/tr>\n
11:00<\/td>\nEffects of venotonic drugs on the microcirculation: Comparison between ruscus extract and diosmine. <\/strong>Eliete Bouskela<\/em><\/td>\n<\/td>\n<\/tr>\n
11:15<\/td>\nCyclo 3. New clinical meta analysis. <\/strong>Stavros Kakkos<\/em><\/td>\n<\/td>\n<\/tr>\n
11:30<\/td>\nGuidelines Update.<\/strong> Andrew Nicolaides<\/em><\/td>\n<\/td>\n<\/tr>\n
11:45<\/td>\nDiscussion. <\/strong>Arkadiusz Jawien, Armando Mansilha<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Industry Sponsored Symposia Click here to download the Programme Thursday, June 29, 2017 12:00 \u2013 13:00\u00a0 Industry Session: Progression of Chronic Venous Disease: Where are we today?(Supported by an educational grant from Servier) Chairperson(s): Armando Mansilha, Andre Van Rij Archive Room 12:00 Evolution of chronic venous disease. Update of epidemiological \u2026 Continue reading → <\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-onecolumn.php","meta":{"_exactmetrics_skip_tracking":false,"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-2657","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2657","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/comments?post=2657"}],"version-history":[{"count":2,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2657\/revisions"}],"predecessor-version":[{"id":2661,"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/pages\/2657\/revisions\/2661"}],"wp:attachment":[{"href":"https:\/\/europeanvenousforum.org\/index.php\/wp-json\/wp\/v2\/media?parent=2657"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}